• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人红白血病细胞上P2嘌呤能受体的特性研究

Characterization of P2 purinergic receptors on human erythro leukemia cells.

作者信息

Akbar G K, Dasari V R, Sheth S B, Ashby B, Mills D C, Kunapuli S P

机构信息

Department of Physiology, Temple University School of Medicine, Philadelphia PA 19140, USA.

出版信息

J Recept Signal Transduct Res. 1996 May-Jul;16(3-4):209-24. doi: 10.3109/10799899609039949.

DOI:10.3109/10799899609039949
PMID:8897312
Abstract

We have investigated the nature of the nucleotide receptors on human erythro leukemia (HEL) cells, a cell line with some megakaryocytic properties, using a combination of pharmacological, photoaffinity labeling, and molecular biological techniques. Fura-2 loaded HEL cells responded to 2-methylthio ATP, ATP, 2-methylthio ADP, ADP and UTP with an increase in intracellular calcium. 2 Methylthio ADP was the most potent agonist. When external calcium was chelated with EDTA, calcium responses were observed indicating the mobilization of intracellular stores. These responses showed evidence of both homologous and heterologous receptor desensitization. In photoaffinity labeling experiments, beta-[32P]-AzPET-ADP was incorporated into three protein species with mobilities corresponding to M(r) approximately 55 kDa (doublet) and approximately 43 kDa. Labeling of approximately 55 kDa proteins was specifically inhibited by ADP, while that of the approximately 43 kDa was inhibited specifically by UTP. Nucleotide sequence analysis of the positive clones obtained by screening the HEL cell cDNA library with mouse P2U cDNA revealed that the P2U receptor from HEL cells is identical to the previously cloned human P2U receptor. These experiments suggest that the HEL cells contain a P2Y purinoceptor responding to ADP, in addition to a P2U receptor and possibly also a third P2 purinoceptor with a unique agonist profile.

摘要

我们运用药理学、光亲和标记及分子生物学技术相结合的方法,研究了人类红白血病(HEL)细胞(一种具有某些巨核细胞特性的细胞系)上核苷酸受体的性质。负载了Fura-2的HEL细胞对2-甲硫基ATP、ATP、2-甲硫基ADP、ADP和UTP产生反应,细胞内钙含量增加。2-甲硫基ADP是最有效的激动剂。当用EDTA螯合细胞外钙时,仍观察到钙反应,这表明细胞内储存钙的动员。这些反应显示出同源和异源受体脱敏的证据。在光亲和标记实验中,β-[³²P]-AzPET-ADP掺入了三种蛋白质,其迁移率分别对应于约55 kDa(双峰)和约43 kDa的分子量。约55 kDa蛋白质的标记被ADP特异性抑制,而约43 kDa蛋白质的标记被UTP特异性抑制。用小鼠P2U cDNA筛选HEL细胞cDNA文库获得的阳性克隆的核苷酸序列分析表明,HEL细胞的P2U受体与先前克隆的人类P2U受体相同。这些实验表明,HEL细胞除了含有对ADP有反应的P2Y嘌呤受体外,还含有一个P2U受体,可能还含有第三个具有独特激动剂谱的P2嘌呤受体。

相似文献

1
Characterization of P2 purinergic receptors on human erythro leukemia cells.人红白血病细胞上P2嘌呤能受体的特性研究
J Recept Signal Transduct Res. 1996 May-Jul;16(3-4):209-24. doi: 10.3109/10799899609039949.
2
Human erythroleukemic (HEL) cells express a platelet P2T-like ADP receptor.人红白血病(HEL)细胞表达一种血小板P2T样ADP受体。
Thromb Res. 1995 Feb 1;77(3):235-47. doi: 10.1016/0049-3848(95)91611-n.
3
Separate P2T and P2U purinergic receptors with similar second messenger signaling pathways in UMR-106 osteoblasts.在UMR-106成骨细胞中分离具有相似第二信使信号通路的P2T和P2U嘌呤能受体。
J Pharmacol Exp Ther. 1994 Jun;269(3):1049-61.
4
Pharmacological characterization of P2Y receptor subtypes on isolated tiger salamander Müller cells.分离的虎蝾螈米勒细胞上P2Y受体亚型的药理学特性
Glia. 2003 Apr 15;42(2):149-59. doi: 10.1002/glia.10198.
5
Osteoblast responses to nucleotides increase during differentiation.在分化过程中,成骨细胞对核苷酸的反应增强。
Bone. 2006 Aug;39(2):300-9. doi: 10.1016/j.bone.2006.02.063. Epub 2006 Apr 17.
6
Presence of functional P2T and P2U purinoceptors on the human megakaryoblastic cell line, Meg-01 characterization by functional and binding studies.人巨核母细胞系Meg-01上功能性P2T和P2U嘌呤受体的存在:通过功能和结合研究进行表征
Nouv Rev Fr Hematol (1978). 1995;37(4):231-40.
7
P2U-purinergic receptors on C6-2B rat glioma cells: modulation of cytosolic Ca2+ and cAMP levels by protein kinase C.C6-2B大鼠胶质瘤细胞上的P2U嘌呤能受体:蛋白激酶C对胞质Ca2+和cAMP水平的调节
Mol Pharmacol. 1993 Dec;44(6):1185-91.
8
Distinct P2Y receptor subtypes regulate calcium signaling in human retinal pigment epithelial cells.不同的P2Y受体亚型调节人视网膜色素上皮细胞中的钙信号传导。
Invest Ophthalmol Vis Sci. 2008 Jan;49(1):350-7. doi: 10.1167/iovs.07-1040.
9
P2Y1-receptors in human platelets which are pharmacologically distinct from P2Y(ADP)-receptors.人血小板中的P2Y1受体在药理学上与P2Y(ADP)受体不同。
Br J Pharmacol. 1998 May;124(1):157-64. doi: 10.1038/sj.bjp.0701827.
10
The P2U purinoceptor obligatorily engages the heterotrimeric G protein G16 to mobilize intracellular Ca2+ in human erythroleukemia cells.P2U嘌呤受体必须与异源三聚体G蛋白G16结合,以动员人红白血病细胞内的Ca2+。
J Biol Chem. 1997 Apr 11;272(15):10151-9. doi: 10.1074/jbc.272.15.10151.

引用本文的文献

1
Purinergic signalling and cancer.嘌呤能信号转导与癌症。
Purinergic Signal. 2013 Dec;9(4):491-540. doi: 10.1007/s11302-013-9372-5.